NEW YORK, Dec. 11, 2023 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Eagle Pharmaceuticals, Inc.:
Due to the forgoing, The Gross Law Firm is investigating potential securities fraud claims on behalf of certain Eagle Pharmaceuticals investors. If you incurred a loss on your EGRX investment, please contact us using the link below to discuss your rights.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
- NOTICE TO THE ANNUAL GENERAL MEETING - May 9, 2025
- SEALSQ to Lead the World’s First Space-Based Quantum Key Distribution Proof-of-Concept with the June 2025 Launch of WISeSat 2.1 Embedding WISeKey Quantum RootKey - May 9, 2025
- Prospect Capital Honored for 2025 Middle-Market Deals of the Year Awards for Druid City Independent Sponsor Investment in Healthcare Industry - May 9, 2025
